Search Results
Nov 11, 2025, 07:00 ET CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
cardiothoracic surgery. The Company is actively pursuing regulatory approval of DrugSorb-ATR with the U.S. FDA and will pursue regulatory approval with Health Canada with better visibility from the FDA. DrugSorb-ATR is not yet granted or approved in either the U.S. or Canada. The
More news about: Cytosorbents Corp
Nov 10, 2025, 15:09 ET interCaribbean Airways Announces New Service San-Juan-St Kitts-San Juan
UK-flagged airline operates 50-seat Embraer ERJ145 Regional Jets, 70 seat Bombardier CRJ700, and a fleet of turboprops, comprising 68-seat ATR72, 48-seat ATR42s, 30-seat EMB120s, and 19-seat Twin Otters. With a network spanning Georgetown, Guyana, in the south, Barbados to the east, Havana, Cuba, to
More news about: interCaribbean Airways
Nov 07, 2025, 06:00 ET Azitra, Inc. Addresses False Report Regarding Sale of Securities
the U.S. Azitra has an open IND for its ATR-04 program in patients with EGFRi associated rash. Azitra is also progressing ATR-01, a preclinical program targeting ichthyosis vulgaris, with the goal of submitting an IND submission in 2026. The ATR-12, ATR-04 and ATR-01 programs were developed from Azitra's proprietary
More news about: Azitra, Inc.
Oct 30, 2025, 07:00 ET CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
cardiothoracic surgery. The Company is actively pursuing regulatory approval of DrugSorb-ATR with the U.S. FDA and will pursue regulatory approval with Health Canada with better visibility from the FDA. DrugSorb-ATR is not yet granted or approved in either the U.S. or Canada. The
More news about: Cytosorbents Corp
Oct 28, 2025, 07:00 ET In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
cardiothoracic procedures. The Company is actively pursuing regulatory approval of DrugSorb-ATR with the U.S. FDA and will pursue regulatory approval with Health Canada with better visibility from the FDA. DrugSorb-ATR is not yet granted or approved in either the U.S. or Canada. The
More news about: Cytosorbents Corp
Oct 27, 2025, 06:00 ET MAB Academy selects CAE to deliver a new Boeing 737MAX full-flight simulator
enhances pilot preparedness and operational confidence. In addition to the new B737MAX FFS, Malaysia Airlines also operates an ATR 72-500 FFS and an A330 NEO FFS, which was certified in September 2025, strengthening the Academy's capacity to meet increasing training requirements.
More news about: CAE Inc.
Oct 20, 2025, 20:22 ET Export Finance Australia issues Conditional Letter of Support for the Donald Project
Oct. 20, 2025 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (Energy Fuels) and Astron Limited (ASX: ATR) (Astron) are pleased to announce that they have received a non-binding and conditional Letter of Support from Export Finance Australia (EFA) (dated
More news about: Energy Fuels Inc.
Oct 20, 2025, 08:02 ET Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris
the U.S. Azitra has an open IND for its ATR-04 program in patients with EGFRi associated rash. Azitra is also progressing ATR-01, a preclinical program targeting ichthyosis vulgaris, with the goal of submitting an IND submission in 2026. The ATR-12, ATR-04 and ATR-01 programs were developed from Azitra's proprietary
More news about: Azitra, Inc.
Oct 15, 2025, 16:05 ET Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit
for EGFRi associated rash, which impacts approximately 150,000 people in the U.S. Azitra has an open IND for its ATR-04 program in patients with EGFRi associated rash. The ATR-12 and ATR-04 programs were developed from Azitra's proprietary platform of engineered proteins and topical live biotherapeutic
More news about: Azitra, Inc.
Oct 08, 2025, 08:08 ET American Staffing Association Names 2026 Board Officers and Directors
Other directors currently serving on the board include Threase Baker, CSP, Abbtech Professional Resources Inc.; Andrea Brenholz, ATR International; Jeffrey S. Burnett, CSP, Labor Finders International Inc.; Benjamin "Ben" Elliott, Randstad; James A. Essey, CSP, TemPositions Group of
More news about: American Staffing Association
Oct 03, 2025, 16:45 ET Azitra Receives Notice of Non-Compliance from NYSE American
for EGFRi associated rash, which impacts approximately 150,000 people in the U.S. Azitra has an open IND for its ATR-04 program in patients with EGFRi associated rash. The ATR-12 and ATR-04 programs were developed from Azitra's proprietary platform of engineered proteins and topical live biotherapeutic
More news about: Azitra, Inc.
Sep 29, 2025, 07:00 ET CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
stated, "We are excited to share new data at EACTS that further validates the important role of CytoSorb® and DrugSorb™-ATR in cardiac surgery. From the first randomized trial results of DrugSorb-ATR in patients on DOACs, to real-world evidence in acute coronary syndrome (ACS) patients undergoing coronary
More news about: Cytosorbents Corp
Sep 29, 2025, 06:48 ET Global Hydrogen Generation Market Size & Share to Surpass $322.3 Billion by 2035, Growing at a CAGR 7.45% | Driving Industrial, Mobility, and Green Energy Transformation
CCS integration for low-carbon hydrogen. Partial Oxidation (POX) & Auto Thermal Reforming (ATR): Supporting transport fuel cells and advanced biofuels. Electrolysis (Alkaline, PEM, Solid Oxide,
More news about: Vantage Market Research
Sep 16, 2025, 07:00 ET CytoSorbents Provides DrugSorb-ATR Regulatory Update
the intended DrugSorb-ATR use population (patients on ticagrelor undergoing urgent coronary artery bypass graft [CABG] surgery), reiterate the device's robust clinical performance in everyday medical practice. Combined with the previously submitted clinical data on DrugSorb-ATR, the Company believes
More news about: Cytosorbents Corp